ImageForNews 764114 16996141230118276
|

More than 314,000 cells analyzed for precise treatment strategies

 

Rheumatoid arthritis (RA) is one of the first autoimmune diseases to be identified and remains incurable. Despite the discovery of several disease-modifying treatments, the response to each treatment remains unpredictable. This indicates a difference in the pathophysiology of RA between patients.

Study: Deconstruction of the synovium of rheumatoid arthritis defines inflammatory subtypes. Image credits: Oporty786/Shutterstock.com
Study: Deconstruction of the synovium of rheumatoid arthritis defines inflammatory subtypes. Image credits: Oporty786/Shutterstock.com

A new article recently appeared in Nature, reported the examination of synovial tissue from the joints of nearly 80 people with RA, combined with RNA sequencing and surface protein analyses. This allowed the researchers to assemble an atlas of RA synovial changes from more than 314,000 individual cells. This could help develop targeted therapies that recognize the diversity of RA disease processes.

Background

RA affects about 1 in 100 people worldwide. The main feature is the painful swelling of synovial joints that ultimately culminates in joint damage and disability. Recognition of the immunological origins of RA has led to the deployment of therapies that target inflammatory cytokines and pathways, including tumor necrosis factor (TNF), IL-6, stimulation of T and B cells together, and the pro-inflammatory JAK -STAT transcription. regulatory process.

Genetic differences have been identified, as well as diverse clinical features, but these do not fully predict or explain why treatment response varies between patients, nor do they help identify therapeutic targets. The need for a more detailed picture of RA synovial disease activity motivated the current study.

Multiple effector cells participate in RA activity at the synovial level. Previous research suggests that the synovial cellular profile could predict response to treatment. Furthermore, the presence of common cell state compounds could extend the utility of this study to other autoimmune or inflammatory conditions.

What does the research show?

The study was based on 82 synovial tissue samples taken from patients with a spectrum of RA activity from moderate to high. This is measured by the CDAI (clinical disease activity index), which was ten or higher for all participants. The samples came from those who had not yet started treatment, some with a poor response to methotrexate (which stops the proliferation of inflammatory cells), those who responded poorly to anti-TNF agents (to stop pro-inflammatory signaling) and some who had osteoarthritis.

The scientists were able to divide the RA synovium into six groups based on the cell types that were selectively enriched in each group. Each group is accordingly called a cell type abundance phenotype (CTAP) and is defined by specific cell states.

While some samples showed very low levels of lymphocytes, others were abundant in T and B cells, indicating clear synovial differences. Each cell state reflects different disease stages and types, as well as varying cytokine profiles, and the risk genes were differentially expressed between groups.

The researchers created an atlas of RA synovial cell states, consisting of 77 cell states, including 24 T cell clusters, 9 B cell clusters, 14 natural killer (NK) cell clusters, and 15 myeloid clusters. There were also ten stromal cells and five endothelial clusters. This confirmed RA-associated cell states identified in a previous study from more than 5,000 synovial cells.

For example, the CTAP-TB was enriched in TPH and TFH cells, perhaps because these promote the differentiation of B cells into plasmablasts and ABC cells, as opposed to non-TFH/TPH memory CD4+ T cells that only do the latter. Both TFH and TPH cells are enriched in the synovial tissue of all CTAPs, but extra-follicular activation pathways also appear to be present in CTAP-TB.

Conversely, the CTAP-TF mainly involves cytotoxic together with naive CD4 and CD8 T cells, with selective NK cells that can share their transcriptional profile promoted by the tissue microenvironment. Fibroblast subsets were differentially enriched in this CTAP versus CTAP-M. The latter also showed enrichment of myeloid cells, perhaps because inflammatory monocytes were recruited to transform into macrophages as a result of exposure to the specific cell types and soluble factors present in each CTAP.

These cell neighborhoods did not show consistent associations with aggregated RA scores from histology, which are based on the extent and type of inflammatory cell infiltration. This is probably because the former are so diverse. However, the CTAPs each contribute one-fifth of the variance of the histological density and total scores and are associated with inflammation scores.

Interestingly, the CTAPs showed a close relationship with clinical parameters such as the commonly used autoantibodies against cyclic citrullinated peptide (CCP), reflecting increased lymphocyte infiltration into CCP-positive synovial tissue. CTAP-M was associated with CCP-negative synovial tissue. There was no clear association with the strongest genetic risk predictor, HLA–DRB1.

The CTAPs showed distinct cytokine profiles. For example, the T cell neighborhood of CTAP-TB expressed the TFH/TPH highlight genes CXCL13 as expected, while for CTAP-TF the T and NK cell neighborhood was associated with the expression of the genes IFNG And TNF.

As expected, there was little correlation between disease activity and CTAP or treatment response. This supports the theory that inflammatory phenotypes in different types of RA are reflected in the CTAPs and not in clinical disease activity, as reflected by CDAI and other clinical scores.

However, CTAPs change over time, usually to CTAP-F, after anti-inflammatory therapies such as rituximab and the anti-IL-6 agent tocilizumab. CTAP-F is a predictor of poor response to treatment.

What are the implications?

“The CTAP paradigm has the potential to serve as a powerful prototype to classify other types of tissue inflammation.” The subtypes of enriched inflammatory cells in different CTAPs also reveal new research questions about how these interact to produce a range of inflammatory phenotypes in such diseases.

“CTAPs are dynamic and can predict response to treatment, highlighting the clinical utility of classifying synovial phenotypes of rheumatoid arthritis.” It was possible to predict the CTAP using RNA sequencing with different methods. This offers potential therapeutic targets for the future.

Meanwhile, the spectrum of inflammatory changes in RA explains why treatment responses vary so widely among patients treated with anti-TNF agents. This may imply that specific therapies that target the cells and pathways enriched in each CTAP could induce better responses, and advance drug development and precision medicine.

Source link

Medical disclaimer: This article is for general information only and is not medical advice, diagnosis or treatment. Always talk to your doctor or a qualified health professional about knee pain or an injury. Get urgent care for severe pain, a knee you cannot put weight on, sudden major swelling, or a hot, red knee with fever. Read our full disclaimer.
Mokhtar Sahraoui

About the author: Mokhtar Sahraoui

Mokhtar Sahraoui is the founder and editor of Knee Hurt. He researches and writes practical, easy-to-understand guides on knee pain, knee injuries, arthritis and recovery, based on trusted medical sources. Knee Hurt articles are general information and are not a substitute for advice from your doctor or physical therapist.

Similar Posts

  • |

    Best knee scooter post-surgery

    Is hopping around on one leg or battling clumsy crutches the only way to get through recovery after a foot or ankle procedure? For many, traditional crutches are a source of frustration and fatigue. They demand considerable arm strength and often lead to instability. This can make you feel trapped and dependent on others. best knee scooter post-surgery There is a more comfortable and popular solution. Studies show that 90 percent of patients prefer using a knee scooter over crutches during their healing period. Occupational therapists highlight a key benefit: these aids keep your injured foot correctly elevated and non-weight bearing. This proper positioning is vital for a smooth recovery. We’ve done the research for you. Our analysis of the current market identifies devices that provide superior mobility and comfort compared to old-fashioned methods. Selecting the right walker helps you maintain your independence. It allows for safer movement around your home and community. A sturdy, well-designed walker is a much more stable alternative to risky hopping. Our expert-driven guide reviews the leading models available. The goal is to help you find reliable equipment that protects your leg while letting you continue with daily life. Key Takeaways The vast majority of patients prefer knee scooters to traditional crutches for recovery. These devices properly elevate the leg, which is essential for non-weight bearing healing. They promote greater independence and reduce reliance on others during your recovery. Choosing a high-quality model significantly improves safety and overall comfort. Our guide provides an expert analysis of the top mobility aids on the market today. A stable walker minimizes the risk of falls and accidental weight-bearing. Informed selection helps you navigate your environment with confidence and ease. Understanding Knee Scooters in Post-Surgery Recovery Patients seeking a stable alternative to crutches frequently turn to rolling walkers with a knee platform. This device, often called a knee scooter or knee walker, has two to five wheels and a padded rest for your leg. It is designed to keep your injured foot correctly elevated. This positioning is completely non-weight bearing, which is vital for healing. Unlike traditional crutches, a knee walker does not demand much arm strength. You simply rest your leg on the cushioned platform and propel yourself forward. This reduces physical exertion dramatically during daily movement. Occupational therapists note an overwhelming patient preference for this mobility aid. We have found that nearly 90 percent of users prefer it over other options. The design helps prevent reinjury caused by balance struggles. Feature Knee Scooter/Walker Traditional Crutches Weight-Bearing Non-weight bearing, leg elevated Partial weight on arms and shoulders Upper Body Strain Minimal; uses leg for support High; requires arm strength Hands-Free Operation Yes; handlebars for steering No; hands occupied Stability on Flat Surfaces Very stable with multiple wheels Less stable; two points of contact Risk of Reinjury Low; proper leg positioning Higher; balance challenges These devices are essential for maintaining independence. They allow you to perform household tasks while your injury heals. By keeping your hands free, a knee scooter lets you carry items and engage in daily life more effectively. Benefits of Using Knee Scooters Over Crutches The journey to regain mobility after surgery doesn’t have to be a struggle against discomfort and instability. While traditional crutches are less expensive, they frequently cause pain and balance issues for active individuals. A knee walker provides a stable base for movement. It allows you to navigate both indoors and outdoors without the constant fatigue linked to crutches. benefits of knee scooter over crutches Occupational therapists emphasize that a knee scooter is a superior choice if you lack upper body strength. Using this device greatly lowers your chance of a fall compared to balancing on underarm crutches. These aids offer a level of freedom that lets you spend time outside. This activity is proven to speed up the healing process. Choosing the right knee walker ensures you can maintain your daily routine. You avoid the physical limits imposed by standard crutches. A quality knee scooter supports your injured leg correctly, promoting safer recovery….

  • |

    Knee Pain Relief

    Knee Pain Relief: Effective Strategies to Alleviate Discomfort If you’re experiencing knee pain, you’re not alone. Knee pain is a common complaint, affecting people of all ages and lifestyles. Knee pain can be caused by a variety of factors, including injury, overuse, or underlying medical conditions such as arthritis. Regardless of the cause, knee pain…

  • |

    Tips for Parenting with Rheumatoid Arthritis

      Parenting is hard at first – but rewarding. Add a chronic condition like RA to the mix, and that delicate balance between your self-care and your role as a parent can easily get lost. These tips and strategies can help you get through difficult days, manage your energy, and make meaningful memories with your…

  • Understanding Knee Osteoarthritis Causes

    At some point in our lives, many of us may experience knee pain or discomfort. This can be attributed to various factors, one of which is knee osteoarthritis. Understanding the causes of knee osteoarthritis is crucial in order to better manage and prevent its progression. Knee osteoarthritis is primarily caused by the degeneration of the…

  • |

    Best Compression Sleeves for Osteoarthritis Knee Pain in 2026 (Top Picks & What Actually Works)

    Did you know that in early knee osteoarthritis, wearing a simple compression sleeve can reduce joint loading by up to 14% during walking? That small mechanical change can make a real difference when your knee hurt starts interfering with daily life. Key Takeaways Question Answer Do compression sleeves help knee pain? Yes, they improve circulation,…

  • NYU Langone receives $9.8 million to advance pediatrics

      Gift establishes the Sala Elbaum Pediatric Research Scholars Program and the Sala Elbaum Fellowship Endowment Fund. NEW YORK , Oct. 30, 2023 /PRNewswire/ — NYU Langone Health’s Department of Pediatrics has received $9.8 million from Trudy Elbaum Gottesman and Robert W. Gottesman, founders of the Sala Institute for Child and Family Centered Care, which…

4 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *